Germann Peter, Braschi Antonio, Della Rocca Giorgio, Dinh-Xuan Anh Tuan, Falke Konrad, Frostell Claes, Gustafsson Lars E, Hervé Philippe, Jolliet Philippe, Kaisers Udo, Litvan Hector, Macrae Duncan J, Maggiorini Marco, Marczin Nandor, Mueller Bernd, Payen Didier, Ranucci Marco, Schranz Dietmar, Zimmermann Rainer, Ullrich Roman
Department of Anaesthesiology and General Intensive Care, Medical University of Vienna, Waehringerguertel 18-20, 1090 Vienna, Austria.
Intensive Care Med. 2005 Aug;31(8):1029-41. doi: 10.1007/s00134-005-2675-4. Epub 2005 Jun 23.
Inhaled nitric oxide (iNO) has been used for treatment of acute respiratory failure and pulmonary hypertension since 1991 in adult patients in the perioperative setting and in critical care.
This contribution assesses evidence for the use of iNO in this population as presented to a expert group jointly organised by the European Society of Intensive Care Medicine and the European Association of Cardiothoracic Anaesthesiologists.
Expert recommendations on the use of iNO in adults were agreed on following presentation of the evidence at the expert meeting held in June 2004.
自1991年以来,吸入一氧化氮(iNO)已用于围手术期和重症监护的成年患者,以治疗急性呼吸衰竭和肺动脉高压。
本论文评估了向由欧洲重症医学会和欧洲心胸麻醉医师协会联合组织的专家组提交的关于在该人群中使用iNO的证据。
在2004年6月举行的专家会议上,在展示证据之后,就iNO在成人中的使用达成了专家建议。